361
Views
72
CrossRef citations to date
0
Altmetric
Review

Factors associated with clinical inertia: an integrative review

, , , , , , & show all
Pages 141-147 | Published online: 08 May 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Jeffrey C. Mecham, Marisa M. Salazar, Rachel M. Perez, Uriel Castaneda, Beatriz Garcia Stamps, Augustine S. Chavez & Juliana M. Kling. (2022) Exploring the Factors that Influence Ethical Spanish Use among Medical Students and Solutions for Improvement. Teaching and Learning in Medicine 34:5, pages 522-529.
Read now
Phoomjai Sornsenee, Polathep Vichitkunakorn, Kittisakdi Choomalee & Chonticha Romyasamit. (2021) Effect of the COVID-19 Pandemic and Other Predictors of True Therapeutic Inertia on Patients with Hypertension in a Primary Care Clinic in Thailand. Risk Management and Healthcare Policy 14, pages 3807-3816.
Read now
Vicente Pallarés-Carratalá, Irene Bonig-Trigueros, Antonio Palazón-Bru, María José Esteban-Giner, Vicente Francisco Gil-Guillén & Vicente Giner-Galvañ. (2019) Clinical inertia in hypertension: a new holistic and practical concept within the cardiovascular continuum and clinical care process. Blood Pressure 28:4, pages 217-228.
Read now
José Antonio García-Macías, Antonio Palazón-Bru, María Ángeles Carbonell-Torregrosa, Miguel Navarro-Juan & Vicente Francisco Gil-Guillén. (2019) Therapeutic inertia in anti-platelet therapy in patients with a cardiovascular event attended in an emergency department. Current Medical Research and Opinion 35:3, pages 455-459.
Read now
Eric L. Johnson, Juan P. Frias & Jennifer M. Trujillo. (2018) Anticipatory guidance in type 2 diabetes to improve disease management; next steps after basal insulin. Postgraduate Medicine 130:4, pages 365-374.
Read now

Articles from other publishers (67)

Aditya Bhat, Sowmiya Karthikeyan, Henry H.L. Chen, Gary C.H. Gan, A. Robert Denniss & Timothy C. Tan. (2023) Barriers to Guideline-Directed Anticoagulation in Patients With Atrial Fibrillation: New Approaches to an Old Problem. Canadian Journal of Cardiology 39:5, pages 625-636.
Crossref
Peter K Yang, So Youn Park, Sandra L Jackson, Sharon Attipoe-Dorcoo, Elizabeth Gray, Matthew D Ritchey & Laurence S Sperling. (2023) Trends and Characteristics of Blood Pressure Prescription Fills Before and During the COVID-19 Pandemic in the United States. American Journal of Hypertension.
Crossref
Liying Dai, Tashi Dorje, Jan Gootjes, Amit Shah, Lawrence Dembo, Jamie Rankin, Graham Hillis, Suzanne Robinson, John J Atherton, Angela Jacques, Christopher M Reid & Andrew Maiorana. (2023) P rimary care A dherence T o H eart F ailure guidelines IN D iagnosis, E valuation and R outine management (PATHFINDER): a randomised controlled trial protocol . BMJ Open 13:3, pages e063656.
Crossref
Allison A. Lewinski, Shelley A. Jazowski, Karen M. Goldstein, Colette Whitney, Hayden B. Bosworth & Leah L. Zullig. (2022) Intensifying approaches to address clinical inertia among cardiovascular disease risk factors: A narrative review. Patient Education and Counseling 105:12, pages 3381-3388.
Crossref
Kotchakorn Dulyapach, Pitchayanont Ngamchaliew, Polathep Vichitkunakorn, Phoomjai Sornsenee & Kittisakdi Choomalee. (2022) Prevalence and Associated Factors of Delayed Diagnosis of Type 2 Diabetes Mellitus in a Tertiary Hospital: A Retrospective Cohort Study. International Journal of Public Health 67.
Crossref
Ricardo Acayaba de Toledo, Felipe Merchan Ferraz Grizzo, Vander Fernandes, Renato Calheiros, Ricardo T. Russo, Gustavo Rosal, Luiz Roberto Delboni Marchese, Roberto Tunala, Renato Watanabe, Marina Gabriela Birck, Guilherme Silva Julian & Francisco Jose Forestiero. (2022) Maintained activity in ankylosing spondylitis patients treated with TNFi and/or NSAID for at least 12 weeks: a cross-sectional study in Brazil. Advances in Rheumatology 62:1.
Crossref
Azka Latif, Muhammad Junaid Ahsan, Noman Lateef, Vikas Kapoor, Amy Tran, Waiel Abusnina, Scott Lundgren, Andrew Goldsweig, Muhammad Zoraiz Ahsan & Mohsin Mirza. (2022) Implementation of Multiple Evidence-Based Heart Failure Therapies. Current Problems in Cardiology 47:10, pages 101293.
Crossref
Piranee Kaewbut, Natapong Kosachunhanun, Arintaya Phrommintikul, Dujrudee Chinwong, John J. Hall & Surarong Chinwong. (2022) Time to Treatment Intensification to Reduce Diabetes-Related Complications: A Post Hoc Study. Healthcare 10:9, pages 1673.
Crossref
Gauravpal S. Gill, Azka Latif, Daniel Hilleman, Carl J. Lavie & Venkata M. Alla. (2022) Challenges in Implementing Evidence Based Cross-Disciplinary Therapies: Are Cardiovascular Specialists Ready to Claim SGLT-2 Inhibitors and GLP-1 Analogs?. Current Problems in Cardiology 47:7, pages 100878.
Crossref
Caroline V.M. Rebicki, Bridget L. Ryan, Alexandria Ratzki-Leewing, Paul F. Tremblay & Stewart B. Harris. (2022) Family Physician Clinical Inertia in Managing Hypoglycemia. Primary Care Diabetes 16:3, pages 417-421.
Crossref
Paulina K. Wrzal, Amir A. Mohseni, Carl Fournier, Ronald Goldenberg, Debbie Hollahan, Susie Jin, Sue D. Pedersen, Michael Vallis, Andrean Bunko, Varun Myageri, Atif Kukaswadia, Calum S. Neish & Noah M. Ivers. (2022) A Cross-sectional Survey to Assess Reasons for Therapeutic Inertia in People With Type 2 Diabetes Mellitus and Preferred Strategies to Overcome It From the Perspectives of Persons With Diabetes and General/Family Practitioners: Results From the MOTION Study. Canadian Journal of Diabetes 46:4, pages 337-345.e2.
Crossref
Beth Towery Davidson & Sabrina Dunham. (2022) The Perfect Storm. Critical Care Nursing Clinics of North America 34:2, pages 141-150.
Crossref
Adam J. Nelson, Kevin Haynes, Sonali Shambhu, Zubin Eapen, Mark J. Cziraky, Michael G. Nanna, Sara B. Calvert, Kerrin Gallagher, Neha J. Pagidipati & Christopher B. Granger. (2022) High-Intensity Statin Use Among Patients With Atherosclerosis in the U.S.. Journal of the American College of Cardiology 79:18, pages 1802-1813.
Crossref
Nemanja Isajev, Vesna Bjegovic-Mikanovic, Zoran Bukumiric, David Vrhovac & Nebojsa M. Lalic. (2022) Predictors of Clinical Inertia and Type 2 Diabetes: Assessment of Primary Care Physicians and Their Patients. International Journal of Environmental Research and Public Health 19:8, pages 4436.
Crossref
Melanie Lam, Anelsa Beqo & Ricky Thumar. (2021) Overcoming Cough and Angioedema: Advocating for the Use of ARBs Over ACE Inhibitors. Annals of Pharmacotherapy 56:3, pages 358-362.
Crossref
Paulina K. Wrzal, Amir A. Mohseni, Carl Fournier, Ronald Goldenberg, Debbie Hollahan, Susie Jin, Sue D. Pedersen, Michael Vallis, Andrean Bunko, Varun Myageri, Atif Kukaswadia, Calum S. Neish & Noah M. Ivers. (2022) Persons With Diabetes and General/Family Practitioner Perspectives Related to Therapeutic Inertia in Type 2 Diabetes Mellitus Using Qualitative Focus Groups and the Theoretical Domains Framework: Results From the MOTION Study. Canadian Journal of Diabetes 46:2, pages 171-180.
Crossref
Nika Mardetko, Urska Nabergoj Makovec, Igor Locatelli, Andrej Janez & Mitja Kos. (2021) Uptake of new antidiabetic medicines in 11 European countries. BMC Endocrine Disorders 21:1.
Crossref
S. R. Gilyarevsky. (2021) Influence of standard heart failure therapy on readmission rate: opportunities and limitations in modern clinical practice. Russian Journal of Cardiology 26:10, pages 4699.
Crossref
Camelia Bucsa, Andreea Farcas, Irina Iaru, Cristina Mogosan & Adriana Rusu. (2021) Drug utilisation study of antidiabetic medication during 2012‐2019 in Romania. International Journal of Clinical Practice 75:11.
Crossref
Caroline Verhestraeten, Ward A. Heggermont & Michael Maris. (2020) Clinical inertia in the treatment of heart failure: a major issue to tackle. Heart Failure Reviews 26:6, pages 1359-1370.
Crossref
Davida F. KrugerJohn E. Anderson. (2021) Continuous Glucose Monitoring (CGM) Is a Tool, Not a Reward: Unjustified Insurance Coverage Criteria Limit Access to CGM. Diabetes Technology & Therapeutics 23:S3, pages S-45-S-55.
Crossref
Angela Dardano, Giuseppe Daniele, Giuseppe Penno, Roberto Miccoli & Stefano Del Prato. (2021) Breaking Therapeutic Inertia With Alirocumab in an 80-Year-Old Patient With Severe Hypercholesterolemia: A Case Report. Frontiers in Medicine 8.
Crossref
Nikolaus Marx, Lars Ryden, Frank Brosius, Antonio Ceriello, Michael Cheung, Francesco Cosentino, Jennifer Green, Monika Kellerer, Susan Koob, Mikhail Kosiborod, T. Prashant Nedungadi, Helena W. Rodbard, Per Olav Vandvik, Linong Ji, Wayne Huey-Herng Sheu, Eberhard Standl & Oliver Schnell. (2021) Towards living guidelines on cardiorenal outcomes in diabetes: A pilot project of the Taskforce of the Guideline Workshop 2020. Diabetes Research and Clinical Practice 177, pages 108870.
Crossref
Yuting Fan, Enwu Long, Lulu Cai, Qiyuan Cao, Xingwei Wu & Rongsheng Tong. (2021) Machine Learning Approaches to Predict Risks of Diabetic Complications and Poor Glycemic Control in Nonadherent Type 2 Diabetes. Frontiers in Pharmacology 12.
Crossref
Paulina K. Wrzal, Andrean Bunko, Varun Myageri, Atif Kukaswadia, Calum S. Neish & Noah M. Ivers. (2021) Strategies to Overcome Therapeutic Inertia in Type 2 Diabetes Mellitus: A Scoping Review. Canadian Journal of Diabetes 45:3, pages 273-281.e13.
Crossref
M. N. Gynnild, R. Aakerøy, O. Spigset, T. Askim, M. K. Beyer, H. Ihle‐Hansen, R. Munthe‐Kaas, A. B. Knapskog, S. Lydersen, H. Næss, T.G. Røsstad, Y. M. Seljeseth, P. Thingstad, I. Saltvedt & H. Ellekjær. (2020) Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke. Journal of Internal Medicine 289:3, pages 355-368.
Crossref
Michelle M. Cloutier, Lara J. Akinbami, Paivi M. Salo, Michael Schatz, Tregony Simoneau, Jesse C. Wilkerson, Gregory Diette, Kurtis S. Elward, Anne Fuhlbrigge, Jacek M. Mazurek, Lydia Feinstein, Sonja Williams & Darryl C. Zeldin. (2020) Use of National Asthma Guidelines by Allergists and Pulmonologists: A National Survey. The Journal of Allergy and Clinical Immunology: In Practice 8:9, pages 3011-3020.e2.
Crossref
Joshua N. LibermanTigwa DavisJacqui PesaWing ChowJohn VerbanacSara Heverly-FittCharles Ruetsch. (2020) Predicting Incident Treatment-Resistant Depression: A Model Designed for Health Systems of Care. Journal of Managed Care & Specialty Pharmacy 26:8, pages 987-995.
Crossref
William David Strain & Päivi Maria Paldánius. (2020) Effect of clinical inertia and trial participation in younger and older adults with diabetes having comorbidities and progressive complications. Diabetes Research and Clinical Practice 166, pages 108310.
Crossref
Nikolaus MarxLars RydénFrank BrosiusAntonio CerielloMichael CheungFrancesco CosentinoJennifer GreenMonika KellererSusan KoobMikhail KosiborodPrashant NedungadiHelena W. RodbardPer Olav VandvikEberhard StandlOliver Schnell. (2020) Proceedings of the Guideline Workshop 2019: Strategies for the Optimization of Guideline Processes in Diabetes, Cardiovascular Diseases, and Kidney Diseases. Diabetes Technology & Therapeutics 22:7, pages 546-552.
Crossref
Nikolaus Marx, Lars Rydén, Frank Brosius, Antonio Ceriello, Michael Cheung, Francesco Cosentino, Jennifer Green, Monika Kellerer, Susan Koob, Mikhail Kosiborod, Prashant Nedungadi, Helena W. Rodbard, Per Olav Vandvik, Eberhard Standl & Oliver Schnell. (2020) Proceedings of the Guideline Workshop 2019 – Strategies for the optimization of guideline processes in diabetes, cardiovascular diseases and kidney diseases. Diabetes Research and Clinical Practice 162, pages 108092.
Crossref
Carla Cox & Diana Isaacs. (2020) Why Are We Stuck? Therapeutic Inertia in Diabetes Education. Diabetes Spectrum 33:1, pages 16-21.
Crossref
Elisabetta Iacopi, Alberto Coppelli, Nicola Riitano, Lorenza Abbruzzese, Letizia Pieruzzi, Chiara Goretti & Alberto Piaggesi. (2019) Adherence to guideline recommended medical therapies in type 2 diabetic patients with chronic critical limb ischemia. Diabetes Research and Clinical Practice 158, pages 107898.
Crossref
Noora Almusalam, Jiwon Oh, Maria Terzaghi, Jorge Maurino, Fabien Bakdache, Alonso Montoya, Fernando Caceres & Gustavo Saposnik. (2019) Comparison of Physician Therapeutic Inertia for Management of Patients With Multiple Sclerosis in Canada, Argentina, Chile, and Spain. JAMA Network Open 2:7, pages e197093.
Crossref
Kathi Mooney, Meagan S. Whisenant & Susan L. Beck. (2019) Symptom Care at Home. Medical Care 57:Suppl 1, pages S66-S72.
Crossref
Richard M. BergenstalMark PeyrotDarlene M. DreonVanita R. ArodaTimothy S. BaileyRonald L. BrazgJuan P. FriasMary L. JohnsonDavid C. KlonoffDavida F. KrugerShenaz RamtoolaJulio RosenstockPierre SerusclatRuth S. WeinstockRamachandra G. NaikDavid M. ShearerVivien ZraickBrian L. LevyThomas Behnke, Faramarz Beigi, Richard Bernstein, Anuj Bhargava, Hélène Bihan, Bruce Bode, Klaus Busch, Bertrand Cariou, Bogdan Catargi, Tira Chaicha-Brom, Sudesna Chatterjee, Belinda Childs, Sylvaine Clavel, Andrew Collier, Anne Farret, Leon Fogelfeld, Todd Gress, Markolf Hanefeld, Priscilla Hollander, David Huffman, Christopher Kelly, Mark Kipnes, See Kwok, Steven Leichter, Marc Lévy, Robert Lipetz, Rory McCrimmon, John McKnight, Mark Molitch, Derek Muse, Lyle Myers, Ola Odugbesan, Andreas Pfützner, Daniel Pomposini, Satyan Rajbhandari, Neda Rasouli, John Reed, Ernie Riffer, Jean-Pierre Riveline, Anthony Robinson, Peter Schwarz, Jörg Simon, William Simon, Ajay Sood, Larry Stonesifer, Charles Thivolet, Devjit Tripathy, Carl Vance, Michelle Welch, Alan Wynne & Reza Zaidi. (2019) Implementation of Basal–Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen. Diabetes Technology & Therapeutics 21:5, pages 273-285.
Crossref
Ramzi Shawahna, Mohammad Odeh & Muath Jawabreh. (2019) Factors Promoting Clinical Inertia in Caring for Patients with Dyslipidemia: A Consensual Study Among Clinicians who Provide Healthcare to Patients with Dyslipidemia. Journal of the National Medical Association 111:1, pages 18-27.
Crossref
Carlos de Diego & Julio Núñez. (2019) Paciente «estable» con insuficiencia cardiaca: el momento oportuno. Revista Española de Cardiología Suplementos 18, pages 11-16.
Crossref
Joel Rodriguez-Saldana. 2019. The Diabetes Textbook. The Diabetes Textbook 367 380 .
Roland E. Schmieder, Diethelm Tschöpe, Cornelia Koch, Taoufik Ouarrak & Anselm K. Gitt. (2018) Individualised treatment targets in patients with type-2 diabetes and hypertension. Cardiovascular Diabetology 17:1.
Crossref
Jennifer Okemah, John Peng & Manuel Quiñones. (2018) Addressing Clinical Inertia in Type 2 Diabetes Mellitus: A Review. Advances in Therapy 35:11, pages 1735-1745.
Crossref
Luciano A. Sposato, Devin Stirling & Gustavo Saposnik. (2018) Therapeutic Decisions in Atrial Fibrillation for Stroke Prevention: The Role of Aversion to Ambiguity and Physicians' Risk Preferences. Journal of Stroke and Cerebrovascular Diseases 27:8, pages 2088-2095.
Crossref
Nancy Luo, Nicholas G. Ballew, Emily C. O'Brien, Melissa A. Greiner, Pamela N. Peterson, Bradley G. Hammill, N. Chantelle Hardy, Warren K. Laskey, Paul A. Heidenreich, Chun-Lan Chang, Adrian F. Hernandez, Lesley H. Curtis, Robert J. Mentz & Gregg C. Fonarow. (2018) Early impact of guideline publication on angiotensin-receptor neprilysin inhibitor use among patients hospitalized for heart failure. American Heart Journal 200, pages 134-140.
Crossref
Tatiana Christides. (2018) Older Adults’ Beliefs, Knowledge and Preferences for Achieving Healthy Vitamin D Status: A Narrative Review. Geriatrics 3:2, pages 26.
Crossref
Michelle M. Cloutier, Paivi M. Salo, Lara J. Akinbami, Richard D. Cohn, Jesse C. Wilkerson, Gregory B. Diette, Sonja Williams, Kurtis S. Elward, Jacek M. Mazurek, Jovonni R. Spinner, Tracey A. Mitchell & Darryl C. Zeldin. (2018) Clinician Agreement, Self-Efficacy, and Adherence with the Guidelines for the Diagnosis and Management of Asthma. The Journal of Allergy and Clinical Immunology: In Practice 6:3, pages 886-894.e4.
Crossref
Manel Mata‐Cases, Josep Franch‐Nadal, Jordi Real, Mònica Gratacòs, Flora López‐Simarro, Kamlesh Khunti & Dídac Mauricio. (2017) Therapeutic inertia in patients treated with two or more antidiabetics in primary care: F actors predicting intensification of treatment . Diabetes, Obesity and Metabolism 20:1, pages 103-112.
Crossref
Fergus William Gardiner, Ezekiel Uba Nwose, Phillip Taderera Bwititi, Judith Crockett & Lexin Wang. (2018) Blood glucose and pressure controls in diabetic kidney disease: Narrative review of adherence, barriers and evidence of achievement. Journal of Diabetes and its Complications 32:1, pages 104-112.
Crossref
G. Reach, V. Pechtner, R. Gentilella, A. Corcos & A. Ceriello. (2017) Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus. Diabetes & Metabolism 43:6, pages 501-511.
Crossref
Elizabeth J. SiembidaArchana RadhakrishnanSarah A. NowakAndrew M. ParkerCraig Evan Pollack. (2017) Linking Reminders and Physician Breast Cancer Screening Recommendations: Results From a National Survey. JCO Clinical Cancer Informatics:1, pages 1-10.
Crossref
Geert Goderis, Bert Vaes, Marjan Van den Akker, Steven Elli, Chantal Mathieu, Frank Buntinx & Séverine Henrard. (2017) Factors associated with Prolonged Inaction in the hypoglycaemic treatment in people with non-insulin dependent Type 2 Diabetes and elevated glycated haemoglobin: A registry-based cohort study. Primary Care Diabetes 11:5, pages 482-489.
Crossref
Mélanie Sustersic, Aurélie Gauchet, Alison Foote & Jean-Luc Bosson. (2017) How best to use and evaluate Patient Information Leaflets given during a consultation: a systematic review of literature reviews. Health Expectations 20:4, pages 531-542.
Crossref
Gabriela García Morales & Magali Reyes Jiménez. (2017) Inercia clínica en pacientes con diabetes mellitus tipo 2 en una unidad de medicina familiar de Acapulco Guerrero, México. Atención Familiar 24:3.
Crossref
Ross D. Feldman, Lisheng Liu, Zhaosu Wu, Yuqing Zhang, Xueqing Yu & Xin-Hua Zhang. (2017) Hypertension Attitude PersPEctives and Needs (HAPPEN): A Real-World Survey of Physicians and Patients With Hypertension in China. The Journal of Clinical Hypertension 19:3, pages 256-264.
Crossref
Bernhard Kulzer. (2017) 11 Tipps, um Diabetiker bei der Stange zu haltenAdherence problems and clinical inertia. 11 strategies keeping patients with diabetes onboard. MMW - Fortschritte der Medizin 159:4, pages 67-72.
Crossref
Kathi H. Mooney, Susan L. Beck, Bob Wong, William Dunson, Debra Wujcik, Meagan Whisenant & Gary Donaldson. (2017) Automated home monitoring and management of patient-reported symptoms during chemotherapy: results of the symptom care at home RCT. Cancer Medicine 6:3, pages 537-546.
Crossref
Kim L. Lavoie, Joshua A. RashTavis S. Campbell. (2017) Changing Provider Behavior in the Context of Chronic Disease Management: Focus on Clinical Inertia. Annual Review of Pharmacology and Toxicology 57:1, pages 263-283.
Crossref
Clifford J. Bailey. (2016) Under-treatment of type 2 diabetes: Causes and outcomes of clinical inertia. International Journal of Clinical Practice 70:12, pages 988-995.
Crossref
Michael H Olsen, Sonia Y Angell, Samira Asma, Pierre Boutouyrie, Dylan Burger, Julio A Chirinos, Albertino Damasceno, Christian Delles, Anne-Paule Gimenez-Roqueplo, Dagmara Hering, Patricio López-Jaramillo, Fernando Martinez, Vlado Perkovic, Ernst R Rietzschel, Giuseppe Schillaci, Aletta E Schutte, Angelo Scuteri, James E Sharman, Kristian Wachtell & Ji Guang Wang. (2016) A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. The Lancet 388:10060, pages 2665-2712.
Crossref
Scott D. Solomon, Brian Claggett, Milton Packer, Akshay Desai, Michael R. Zile, Karl Swedberg, Jean Rouleau, Victor Shi, Martin Lefkowitz & John J.V. McMurray. (2016) Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation. JACC: Heart Failure 4:10, pages 816-822.
Crossref
A.-J. Scheen. (2016) Instauration d’une insulinothérapie chez le patient diabétique de type 2 en médecine générale : Comparaison de l’étude belge InsuStar avec quelques études françaises et internationales. Médecine des Maladies Métaboliques 10:4, pages 334-340.
Crossref
Jay Lin, Steve Zhou, Wenhui Wei, Chunshen Pan, Melissa Lingohr-Smith & Philip Levin. (2016) Does Clinical Inertia Vary By Personalized A1C Goal? A Study of Predictors And Prevalence of Clinical Inertia In A U.S. Managed-Care Setting. Endocrine Practice 22:2, pages 151-161.
Crossref
D R J Martínez-St John, A Palazón-Bru, V F Gil-Guillén, A Sepehri, F Navarro-Cremades, D Orozco-Beltrán, C Carratalá-Munuera, E Cortés & M M Rizo-Baeza. (2015) Differences in the management of hypertension, diabetes mellitus and dyslipidemia between obesity classes. Journal of Human Hypertension 30:1, pages 7-10.
Crossref
Michel Krempf, Ross J Simpson, Dena Rosen Ramey, Philippe Brudi, Hilde Giezek, Joanne E Tomassini, Raymond Lee & Michel Farnier. (2015) Patient and physician factors influence decision-making in hypercholesterolemia: a questionnaire-based survey. Lipids in Health and Disease 14:1.
Crossref
Roland E Schmieder, Anselm K Gitt, Cornelia Koch, Peter Bramlage, Taoufik Ouarrak & Diethelm Tschöpe. (2015) Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry. BMC Endocrine Disorders 15:1.
Crossref
Damian RJ Martínez-St John, Antonio Palazón-Bru, Vicente F Gil-Guillén, Armina Sepehri, Felipe Navarro-Cremades, Dolores Ramírez-Prado, Domingo Orozco-Beltrán, Concepción Carratalá-Munuera, Ernesto Cortés & María M Rizo-Baeza. (2015) Diagnostic inertia in obesity and the impact on cardiovascular risk in primary care: a cross-sectional study. British Journal of General Practice 65:636, pages e454-e459.
Crossref
M. Bodí, M. Olona, M. C. Martín, R. Alceaga, J. C. Rodríguez, E. Corral, J. M. Pérez Villares & G. Sirgo. (2015) Feasibility and utility of the use of real time random safety audits in adult ICU patients: a multicentre study. Intensive Care Medicine 41:6, pages 1089-1098.
Crossref
F. Javier Ampudia-BlascoPierre Yves BenhamouGuillaume CharpentierAgostino ConsoliMichaela DiamantBaptist GallwitzKamlesh KhuntiChantal MathieuMartin RidderstråleJochen SeufertCees TackTina VilsbøllTra-Mi PhanHerman Stoevelaar. (2015) A Decision Support Tool for Appropriate Glucose-Lowering Therapy in Patients with Type 2 Diabetes. Diabetes Technology & Therapeutics 17:3, pages 194-202.
Crossref